Compare Mesoblast Limited (MESO) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Standard Lithium Ltd — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Standard Lithium Ltd trades at $2.41 (market cap $604.50M). The key difference: Mesoblast Limited is far larger — about 3.7× Standard Lithium Ltd's market cap, and Mesoblast Limited is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.
| MESO | SLI | |
|---|---|---|
Market Cap | $2.21B | $604.50M |
Sector | Technology | Basic Materials |
52-Week High | $20.96 | $5.65 |
52-Week Low | $12.88 | $1.93 |
Enterprise Value | $2.21B | $467.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
